220127-57-1
Enquire Now
Product CAS No
Product Description
Imatinib mesylate belongs to the signal transduction inhibitor category of targeted therapies. It is particularly a protein-tyrosine kinase inhibitor.
Therapeutic Action
Imatinib is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases).
